MT-ND2 pseudogene 31 (MTND2P31)

MT-ND2 pseudogene 31 is designated as a pseudogene and not a functional protein or enzyme. In genetics, pseudogenes are generally non-functional segments of DNA that resemble functional genes but usually lack the ability to encode a functional protein due to mutations, truncations, or alterations in crucial coding or regulatory regions. Thus, MT-ND2 pseudogene 31 does not produce a functional version of the NADH:ubiquinone oxidoreductase core subunit 2 protein and is not relevant as a therapeutic target, biomarker, or drug interaction partner. There is no evidence in current major biological databases or the scientific literature of MTND2P31 having any biological, pharmacological, or pathological function. The functional gene MT-ND2 (sometimes abbreviated as MTND2) is a mitochondrially encoded component of Complex I and has known roles in mitochondrial electron transport, disease, and metabolism, but the pseudogenes do not share these roles. The designation "pseudogene 31" in standard gene databases (such as HGNC) is recognized as a pseudogene entry and not associated with known biological activity, clinical significance, or druggability. Therapeutic targets are by definition functionally relevant molecules—pseudogenes, unless shown to have regulatory or other roles (which is not the case here), are not considered therapeutic targets. MT-ND2 pseudogene 31 (MTND2P31) is not a valid or recognized therapeutic target. Its only established role is as a DNA sequence without known function or disease relevance. Information relating to drug interactions, biological function, molecular classification (beyond "pseudogene"), and disease association is not applicable. The query likely contains a mistake by listing this pseudogene as a target.

Other names

MTND2P31mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 31MT-ND2P31